4 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 1 | 1 | Terminated 1 |
Follow Elevation Oncology: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 EO-3021, Ramucirumab (CYRAMZA®), Dostarlimab - Stomach Neoplasm, Gastrointestinal Neoplasms | Phase 1 | Terminated | Elevation Oncology | 88 | 2023-08-10 | 2025-11-14 |
| Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors Seribantumab - Locally Advanced Solid Tumor, Metastatic Solid Tumor | Phase 2 | Terminated | Elevation Oncology | 54 | 2020-09-29 | 2025-04-03 |
| Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer Seribantumab, Fulvestrant, Placebo - Metastatic Breast Cancer | Phase 2 | Terminated | Elevation Oncology | 22 | 2017-08-15 | 2020-09-02 |
| A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC MM-121, Docetaxel - Non-Small Cell Lung Cancer, NSCLC | Phase 2 | Terminated | Elevation Oncology | 153 | 2015-02-01 | 2021-10-12 |
Adenocarcinoma (2) · Breast Neoplasms (2) · Fibromatosis, Gingival, 2 (2) · Bile Duct Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Cholangiocarcinoma (1) · Colorectal Neoplasms (1) · Digestive System Neoplasms (1) · Esophageal Neoplasms (1) · Gallbladder Neoplasms (1) · Gastrointestinal Neoplasms (1) · Head and Neck Neoplasms (1) · Kidney Neoplasms (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1)
seribantumab (3) · Docetaxel (1) · Fulvestrant (1) · Histidine (1) · Ramucirumab (1) · Sodium Chloride (1) · dostarlimab (1)
United States (4) · Canada (3) · Germany (2) · South Korea (2) · Spain (2) · Australia (1) · Austria (1) · Belgium (1) · France (1) · Hungary (1) · Japan (1)
Marc Pipas, MD (1)
2017 (1)